Efficacy of Dolutegravir Plus Lamivudine in HIV-1-infected Treatment-naïve Adults Without a Baseline Genotyping Test
Clinical trial NCT04549467 · COMPLETED
Trial details
- NCT number
- NCT04549467
- Sponsor
- Fundacion IDEAA
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-17
- Primary completion
- 2023-09-30
- Enrollment
- 244
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.